German image processing developer Mint Medical has released its new mint Lesion 1.8 software for assessing lymphoma patients.
Features include support for assessing metabolic FDG-PET imaging data, such as of nodules, bone marrow involvement, the spleen, and the liver.
Mint Lesion 1.8 is distributed by Translational Sciences in the U.S. under the brand name OncoTrac. The software has received 510(k) clearance by the U.S. Food and Drug Administration (FDA) and is commercially available for clinical research and patient care.
